National Health Investors (NHI) files Q3 2025 earnings 8-K update

Rhea-AI Filing Summary

National Health Investors, Inc. filed a current report to share that it issued a press release announcing its earnings for the quarter ended September 30, 2025. The company states that this earnings release, dated November 6, 2025, is included as Exhibit 99.1 and incorporated by reference. The filing is made under the Results of Operations and Financial Condition disclosure item, signaling a routine quarterly earnings update rather than a major transaction.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 11/06/2025 - 04:22 PM Learn about SEC filing dates

FAQ

What did National Health Investors (NHI) report in this 8-K?

The company reported that it issued a press release announcing its earnings for the quarter ended September 30, 2025, and filed that release as Exhibit 99.1.

Which period do the National Health Investors (NHI) earnings in this filing cover?

The earnings discussed in this filing cover the quarter ended September 30, 2025.

What exhibit did National Health Investors (NHI) include with this 8-K earnings filing?

National Health Investors included Exhibit 99.1, described as the Third Quarter Earnings Press Release dated November 6, 2025.

Under which disclosure item did National Health Investors (NHI) file this earnings update?

The company filed this update under Item 2.02, Results of Operations and Financial Condition.

Who signed the National Health Investors (NHI) November 6, 2025 8-K?

The report was signed on behalf of National Health Investors, Inc. by John L. Spaid, Chief Financial Officer.

What stock exchange lists National Health Investors (NHI) common stock?

National Health Investors common stock, par value $0.01 per share, is listed on the New York Stock Exchange under the symbol NHI.

0000877860FALSE00008778602025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 6, 2025

National Health Investors Inc

(Exact name of Registrant as specified in its charter)

Maryland			001-10822			62-1470956
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

222 Robert Rose Drive

Murfreesboro, TN 37129

(Address of principal executive offices)

(615) 890-9100

(Registrant's telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year,

if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.01 par value			NHI			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition

On November 6, 2025, National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended September 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits

Exhibit Number						Description
99.1						Third Quarter Earnings Press Release, dated November 6, 2025
104						Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						National Health Investors, Inc.
Date:			November 6, 2025			/s/ John L. Spaid
						Name:			John L. Spaid
						Title:			Chief Financial Officer